GOALS & OBJECTIVES
Establishing Treatment Guidelines For Supportive Care In Patients With Cancer
Perspectives from Johns Hopkins on Local and National Implementation
Activity Date: March 2004  — Activity Info: Volume4, (3B)
Goals & Objectives | Faculty | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired) | Order Copy of Activity

 

GOAL
To provide oncologists, hematologists, hospital decision makers, oncology nurses, and oncology pharmacists with information on the need for and the recent advances in the supportive care of patients with cancer.

TARGET AUDIENCE
This activity is designed for oncologists, hematologists, hospital decision makers, oncology nurses, and oncology pharmacists. No prerequisites required.

LEARNING OBJECTIVES
The Johns Hopkins University School of Medicine, The Institute for Johns Hopkins Nursing, and the University of Tennessee College of Pharmacy take responsibility for the content, quality, and scientific integrity of this CE activity. At the conclusion of this activity, participants should be able to:

  • Discuss the need for supportive care in cancer therapy in terms of complications from anemia, neutropenia, nausea and emesis, and oral mucositis.
  • Identify the advantages and disadvantages of available treatments for anemia, neutropenia, nausea and emesis, and oral mucositis.
  • Discuss the differences between the NCCN and ASCO/ASH guidelines as they relate to supportive care in patients with cancer.
  • Recognize the importance of standardization of care at the local level for patients with cancer.

ACCREDITATION STATEMENT
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Institute for Johns Hopkins Nursing is accredited by the American Nurses Credentialing Center's Commission on Accreditation to provide continuing education for nurses. The University of Tennessee College of Pharmacy is approved by the American Council on Pharmaceutical Education as a provider of continuing pharmaceutical education.

CREDIT DESIGNATION STATEMENT
The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 2 category 1 credits toward the AMA Physician's Recognition Award.

The Institute for Johns Hopkins Nursing designates this educational activity for a maximum of 2 contact hours.

This program is approved for 2 hours (0.2 CEUs) and is cosponsored by the University of Tennessee College of Pharmacy, which is approved by the American Council on Pharmaceutical Education as a provider of continuing pharmaceutical education. A statement of CE credit will be mailed within 4 weeks of successful completion and evaluation of the program. ACPE program #064-999-04-217-H01.

Each participant should claim only those credits that he/she actually spent in the activity.

The estimated time to complete this educational activity: 2 hours.

Release date: March 15, 2004. Expiration date: March 15, 2006.

DISCLAIMER STATEMENT
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of the Johns Hopkins University School of Medicine, The Institute for Johns Hopkins Nursing, and the University of Tennessee College of Pharmacy names implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects, before administering pharmacologic therapy to patients.

This program is supported by an unrestricted educational grant from Amgen Inc.

     
Home | Contact Us | View Account | Need Help?